Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 4Unknown 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Neoplasms 2Obesity 1Leukemia, Myeloid, Acute 1Hyperandrogenism 1Heart Failure 1Critical Illness 1Cardiotoxicity 1Acute Kidney Injury 1

Interventions

Metformin 35Clomiphene 11Letrozole 10Inositol 7Triptorelin Pamoate 5drospirenone and ethinyl estradiol combination 4Progesterone 4Folic Acid 4Ethinyl Estradiol 4Caloric Restriction 4drospirenone 3cetrorelix 3Spironolactone 3Estradiol 3Diet, Mediterranean 3Diet 3Cyproterone acetate, ethinyl estradiol drug combination 3Contraceptives, Oral 3Acupuncture Therapy 3adrenosterone 2Vitamin D 2Ultrasonography 2Thioctic Acid 2Therapeutics 2Sitagliptin Phosphate 2Simvastatin 2Pioglitazone 2Ovidrel 2Musculoskeletal Manipulations 2Hematologic Tests 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Polycystic Ovary Syndrome × Spironolactone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

University of Virginia

Phase NA Unknown
20 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown
24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡